We have a vast experience of working with Insurance companies and private healthcare providers. We work with our clients to develop cancer strategies that are future-proof and ultimately benefit the patients with improved outcomes and evidence-based medicine.
Understanding the costs of cancer is critical and with the use of machine learning, we have developed novel bespoke solutions. Improved treatments can improve both short term toxicity and long term side-effects which can deliver demonstratable cost improvements. Our expertise lay in measuring this and presenting this enormous amount of data in a meaningful format.
Demonstrating a service aligns with evidence-based healthcare is challenging because of the multifactorial nature of cancer. Small variations in practice, even within the research setting, coupled with the diversity within patient demographics make demonstrating evidence-based practice challenging. We have novel solutions to these challenges and can help showcase a service and demonstrate value.
Please feel free to get in touch to discuss your needs with one of our consultants.
The Belgravia Oncology Team